ARCHIVES

William Tipping New ACS Executive VP; Murphy To Replace Holleb, Laszio Takes Rauscher’s Position

This article is from The Cancer Letter archive.

Vol. 14 No. 10 | March 4, 1988

Download PDF Visit The Full Archive

Related Articles

Early HER2 Positive Patients At Higher Risk of Recurrence

January 30, 2009

Clinical Trials Approved By NCI In November

December 28, 2001

President, Congress, Cancer Letter Take Off

August 22, 1986

Six Compounds Carcinogenic, Risk to Humans, CH Subgroup Finds

February 2, 1979

NCI Cooperative Group, Cancer Center Trials Listed

October 28, 2005

NIH Cancer Nurse Turnover Down to 10%

July 24, 1987